Babies Exposed To Cleaning Products May Have Increased Asthma Risk

BOSTON (CBS) – New parents often thoroughly clean their homes to reduce their baby’s exposure to germs, but new research suggests cleaning products could actually increase a child’s risk of asthma. Asthma is the most common chronic disease in childhood. A new study published in the Canadian Medical Association Journal finds that babies under three months of age living in homes where cleaning products are frequently used were more likely to develop wheezing and asthma by age three. The greatest link was with air fresheners, dusting sprays, hand sanitizers, and oven cleaners. Researchers said babies spend more of their time indoors and are particularly vulnerable to chemical exposure because they breathe fast and often come in contact with household surfaces.
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Syndicated CBSN Boston Syndicated Local Asthma Parenting Source Type: news

Related Links:

Publication date: September 2020Source: Advances in Medical Sciences, Volume 65, Issue 2Author(s): Tung Truong-Thanh, Anh Vo-Thi-Kim, Thuc Vu-Minh, Dung Truong-Viet, Huong Tran-Van, Sy Duong-Quy
Source: Advances in Medical Sciences - Category: Biomedical Science Source Type: research
Abstract Mast cells are tissue-resident immune cells that are involved in inflammation and fibrosis but also serve beneficial roles, including tissue maintenance, angiogenesis, pathogen clearance, and immunoregulation. Their multifaceted response and the ability of their mediators to target multiple organs and tissues means that mast cells play important roles in numerous conditions, including asthma, atopic dermatitis, drug sensitivities, ischemic heart disease, Alzheimer disease, arthritis, irritable bowel syndrome, infections (parasites, bacteria and viruses), and cancer. As a result, mast cells have become an ...
Source: Journal of Immunology - Category: Allergy & Immunology Authors: Tags: J Immunol Source Type: research
Authors: Feleszko W, Rossi GA, Krenke R, Canonica GW, van Gerven L, Kalyuzhin O Abstract Introduction: The prevalence of chronic inflammatory airway diseases is rising. Their treatment with corticosteroids increases infection risk, while overuse of antimicrobial agents may increase morbidity and antimicrobial resistance. Non-specific immunomodulatory compounds alter immune responses to both infectious and atopic challenges. These compounds may offer an alternative approach for symptom reduction and prophylaxis against both infections and exacerbations in chronic inflammatory airway disease.Areas covered: We assesse...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
Authors: Widhianingsih D, Koontongkaew S PMID: 32249711 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
Authors: Pade KH, Thompson LR, Ravandi B, Chang TP, Barry F, Halterman JS, Szilagyi PG, Okelo SO Abstract Background: National asthma guidelines recommend use of an asthma action plan (AAP) as part of chronic asthma care. Unfortunately, AAPs have not been tailored for use in acute care settings, where many patients at risk for poor chronic asthma care are seen, including those who are non-English-speaking or have low literacy levels. We previously developed a picture-based medication plan (PBMP), a unique type of AAP for use in an ambulatory setting and designed to increase patient use and understanding. However, l...
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
Publication date: Available online 8 April 2020Source: Pharmacological ResearchAuthor(s): Hock L. Tay, Paul S. Foster
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
Authors: Zhao W, Tan C, Yu X, Yu R, Mei Q, Cheng Y Abstract T helper (Th) cells orchestrate allergic lung inflammation in asthma pathogenesis. Th9 is a novel Th cell subset that mainly produces IL-9, a potent proinflammatory cytokine in asthma. A 7-amino acid peptide (7P) of the hypervariable region 1 (HVR1) of hepatitis C virus has been identified as an important regulator in the type 2 cytokine (IL-4, IL-5, and IL-13) immune response. However, it is unknown whether 7P regulates Th9 cell differentiation during ovalbumin- (OVA-) induced allergic lung inflammation. To address this, we studied wild-type mice treated ...
Source: Journal of Immunology Research - Category: Allergy & Immunology Tags: J Immunol Res Source Type: research
Scott Blanks, 34, of Whittier, had outgrown childhood asthma but couldn't overcome COVID-19.
Source: L.A. Times - Health - Category: Consumer Health News Authors: Source Type: news
AbstractPurpose of ReviewRecent advances have been made in the use of biologic therapies for chronic inflammatory diseases of the unified airway. The purpose of this review is to summarize the current state of knowledge for biologic therapies in chronic airway disease, including indications for use, mechanisms of action, and future needs for research.Recent FindingsThere are currently four classes of FDA-approved biologic therapies for treatment of inflammatory airway diseases: Dupilumab (anti-IL-4R α) is approved for both moderate to severe allergic asthma and chronic rhinosinusitis with nasal polyps, including aspi...
Source: Current Otorhinolaryngology Reports - Category: ENT & OMF Source Type: research
More News: Asthma | Babies | Canada Health | Chemistry | Children | Health | Parenting | Sports Medicine | Study